Live Breaking News & Updates on Genetically Modified Organismpublished

The Alliance for Regenerative Medicine: ARM, EFPIA and EuropaBio Call for Advanced Therapies to be Exempt from EU GMO Legislation
Advanced Therapies
needs
patients
, 2021
Human Gene Therapy.
The European Commission recognized that GMO requirements hinder the conduct of clinical trials in its April 29 study on new genomic techniques and in the 2020 Pharmaceutical Strategy for Europe, when it called for GMO legislation to be fit for purpose for addressing medicines. The original GMO legislation was primarily enacted to protect food consumers and the environment, but Advanced Therapy Medicinal Products (ATMPs) such as gene therapies are affected as an unintended consequence. The uneven application of GMO requirements across EU Member States causes significant clinical trial delays despite findings that gene therapies pose a negligible risk to the environment. ....

United States , Bruxelles Capitale , Kostenloser Wertpapierhandel , Andy Powrie Smith , Paige Bischoff , Violeta Georgieva , Dovile Sandaraite , Regulatory Affairs , European Association For Bioindustries , European Commission , European Federation Of Pharmaceutical Industries , Europabio Legal Affairs Manager , Eu Court , European Association For Bioindustries Europabio , Global Public Affairs , Alliance For Regenerative Medicine , Regenerative Medicine , European Federation , Pharmaceutical Industries , European Association , Bioindustries Call , Advanced Therapiesto , Genetically Modified Organismpublished , Human Gene , Advanced Therapy Medicinal Products , Vice President ,